Biotech entrepreneur Arie Belldegrun launches new ‘science-first’ credit firm

Arie Belldegrun, the founder of Allogene Therapeutics and Kite Pharma, unveiled a new credit firm Tuesday with $600 million to put to work providing loans to biotechnology, medical device and other life sciences companies.